Background Paclitaxel, as a first line anti-neoplastic compound, frequently produces long-term pain after tumors have been treated. Clinical manifestations are varied and non-specific. Pathology of the nervous system during the development of the neuropathic pain is unclear. Thus, early diagnosis and treatment is often unsatisfying for patients. This study aimed to promote considerate understanding of the structural alteration of sensory nerves. Methods All rats were simply randomized into 3 groups: paclitaxel group, vehicle group and saline group. An established rat model of paclitaxel-induced peripheral neuropathy (2 mg/kg) was chosen for our research, behavior tests were operated during the procedure of 56 days. All rats were sampled ...
Indiana University-Purdue University Indianapolis (IUPUI)Although paclitaxel is a commonly used anti...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of multiple ...
Paclitaxel, one of the most commonly used cancer chemotherapeutic drugs, effectively extends the pro...
Peripheral neuropathy is one of the most common side effects of chemotherapy, affecting up to 60% of...
Human and animal studies suggest that both traumatic nerve injury and toxic challenge with chemother...
Paclitaxel (Brand name Taxol) is widely used in the treatment of common cancers like breast, ovarian...
Chemotherapeutic-induced peripheral neuropathy (CIPN) is associated with a unique stocking-glove dis...
Trabajo presentado en el 37th Annual Meeting; European Society for Magnetic Resonance In Medicine a...
Cancer patients undergoing paclitaxel infusion usually experience peripheral nerve degeneration and ...
AbstractPaclitaxel is a first-line chemotherapeutic with the major dose-limiting side effect of pain...
ABSTRACT: Paclitaxel is used in the adjuvant treatment of breast cancer. It induces disabling and po...
By 2030, 4 million people are estimated to survive cancer in the UK. Increased survival rates are th...
ABSTRACT Background: Paclitaxel is a widely used chemotherapeutic drug for breast and ovarian cancer...
Paclitaxel is a common chemotherapeutic that often causes peripheral sensory neuropathy. Paclitaxel ...
Peripheral neuropathy (PN) is a debilitating and dose-limiting side effect of treatment with the che...
Indiana University-Purdue University Indianapolis (IUPUI)Although paclitaxel is a commonly used anti...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of multiple ...
Paclitaxel, one of the most commonly used cancer chemotherapeutic drugs, effectively extends the pro...
Peripheral neuropathy is one of the most common side effects of chemotherapy, affecting up to 60% of...
Human and animal studies suggest that both traumatic nerve injury and toxic challenge with chemother...
Paclitaxel (Brand name Taxol) is widely used in the treatment of common cancers like breast, ovarian...
Chemotherapeutic-induced peripheral neuropathy (CIPN) is associated with a unique stocking-glove dis...
Trabajo presentado en el 37th Annual Meeting; European Society for Magnetic Resonance In Medicine a...
Cancer patients undergoing paclitaxel infusion usually experience peripheral nerve degeneration and ...
AbstractPaclitaxel is a first-line chemotherapeutic with the major dose-limiting side effect of pain...
ABSTRACT: Paclitaxel is used in the adjuvant treatment of breast cancer. It induces disabling and po...
By 2030, 4 million people are estimated to survive cancer in the UK. Increased survival rates are th...
ABSTRACT Background: Paclitaxel is a widely used chemotherapeutic drug for breast and ovarian cancer...
Paclitaxel is a common chemotherapeutic that often causes peripheral sensory neuropathy. Paclitaxel ...
Peripheral neuropathy (PN) is a debilitating and dose-limiting side effect of treatment with the che...
Indiana University-Purdue University Indianapolis (IUPUI)Although paclitaxel is a commonly used anti...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of multiple ...
Paclitaxel, one of the most commonly used cancer chemotherapeutic drugs, effectively extends the pro...